Advanced Technology for Myopia Control in Children and Young Adults

Myopia, or nearsightedness, is increasing rapidly worldwide, especially in children and young adults. This study tested two advanced treatments for slowing myopia progression with one control group: special lenslet spectacles (Stellest with highly aspherical lenslet technology) and violet excitation filter glasses (wavelength 420 nm) and Single vision lenses for controls. The study enrolled 90 participants aged 8 to 20 years from schools and universities in Faisalabad, Pakistan. Participants were randomly assigned to one of three groups: lenslet spectacles, violet filter glasses, or single vision lenses (control group). Visual acuity, contrast sensitivity, Spherical Equivalent and axial length were measured at the start and again after 3, 6, and 9 months and one follow up after cessation of treatment. The study aimed to determine whether these advanced technologies can effectively slow myopia progression compared to standard glasses, providing head-to-head evidence on emerging and established optical interventions for myopia control.

NCT Number	NCT07645183
Lead Sponsor	University of Faisalabad
Conditions	Myopia (Disorder), Refraction Error
Enrollment	90 participants
Start Date	2025-07-01
Primary Completion	2026-05-30 (estimated)
Study Completion	2026-06-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-25